Roger L. Albin

46.4k total citations · 5 hit papers
315 papers, 21.8k citations indexed

About

Roger L. Albin is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Roger L. Albin has authored 315 papers receiving a total of 21.8k indexed citations (citations by other indexed papers that have themselves been cited), including 160 papers in Neurology, 152 papers in Cellular and Molecular Neuroscience and 88 papers in Molecular Biology. Recurrent topics in Roger L. Albin's work include Parkinson's Disease Mechanisms and Treatments (114 papers), Neurological disorders and treatments (99 papers) and Neuroscience and Neuropharmacology Research (80 papers). Roger L. Albin is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (114 papers), Neurological disorders and treatments (99 papers) and Neuroscience and Neuropharmacology Research (80 papers). Roger L. Albin collaborates with scholars based in United States, Italy and Netherlands. Roger L. Albin's co-authors include John B. Penney, Anne B. Young, Kirk A. Frey, Nicolaas I. Bohnen, Robert A. Koeppe, Martijn L.T.M. Müller, J. Timothy Greenamyre, Vikas Kotagal, Karen E. Anderson and A. Byron Young and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Roger L. Albin

310 papers receiving 21.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The functional anatomy of basal ganglia disorders

1989 3.9k citations Roger L. Albin et al. profile →
Differential loss of striatal projection neurons in Huntington disease.

1988 777 citations Roger L. Albin et al. profile →
Alternative excitotoxic hypotheses

1992 457 citations Roger L. Albin et al. Neurology profile →
Current and projected future economic burden of Parkinson’s disease in the U.S.

2020 397 citations Roger L. Albin et al. profile →
Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches

2022 145 citations Nicolaas I. Bohnen, Roger L. Albin et al. profile →

Peers

Countries citing papers authored by Roger L. Albin

Since Specialization

Citations

This map shows the geographic impact of Roger L. Albin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger L. Albin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger L. Albin more than expected).

Fields of papers citing papers by Roger L. Albin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger L. Albin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger L. Albin. The network helps show where Roger L. Albin may publish in the future.

Co-authorship network of co-authors of Roger L. Albin

This figure shows the co-authorship network connecting the top 25 collaborators of Roger L. Albin. A scholar is included among the top collaborators of Roger L. Albin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger L. Albin. Roger L. Albin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cholinergic System Changes in Dopa‐Unresponsive Freezing of Gait in Parkinson's Disease 2025 ·Movement Disorders ·Kelvin L. Chou, Prabesh Kanel, (unknown), (unknown), (unknown), Roger L. Albin, Nicolaas I. Bohnen	0
2	A multicenter longitudinal study of cholinergic subgroups in Parkinson disease 2025 ·Nature Communications ·Nicolaas I. Bohnen, (unknown), Sygrid van der Zee, (unknown), (unknown), (unknown), (unknown), Kirk A. Frey, Peter J. H. Scott, Robert A. Koeppe, Teus van Laar, Roger L. Albin, Prabesh Kanel	1
3	Dynamic balance and gait impairments in Parkinson’s disease: novel cholinergic patterns 2024 ·Brain Communications ·Nicolaas I. Bohnen, Uroš Marušič, (unknown), (unknown), (unknown), (unknown), Peter J. H. Scott, Giulia Carli, Roger L. Albin, Prabesh Kanel	1
4	Update: Protective and risk factors for Parkinson disease 2024 ·Parkinsonism & Related Disorders ·(unknown), Roger L. Albin	8
5	Update: Descriptive epidemiology of Parkinson disease 2024 ·Parkinsonism & Related Disorders ·(unknown), Roger L. Albin	20
6	Salience network segregation mediates the effect of tau pathology on mild behavioral impairment 2024 ·Alzheimer s & Dementia ·Alexandru D. Iordan, Robert Ploutz‐Snyder, Bidisha Ghosh, Annalise Rahman‐Filipiak, Robert A. Koeppe, Scott Peltier, Bruno Giordani, Roger L. Albin, Benjamin M. Hampstead	2
7	Blood‐based biomarkers for Alzheimer's disease and cognitive function from mid‐ to late life 2023 ·Alzheimer s & Dementia ·Xin Wang, Kelly M. Bakulski, Carrie Karvonen‐Gutierrez, Sung Kyun Park, David Morgan, Roger L. Albin, Henry L. Paulson	9
8	Cholinergic innervation topography in GBA-associated de novo Parkinson’s disease patients 2023 ·Brain ·(unknown), Sygrid van der Zee, Giulia Carli, (unknown), Jeffrey M. Boertien, (unknown), Nicolaas I. Bohnen, Roger L. Albin, Teus van Laar	11
9	Lecanemab 2023 ·Neurology ·James Burke, Kevin A. Kerber, Kenneth M. Langa, Roger L. Albin, Vikas Kotagal	40
10	Regional serotonin terminal density in aging human brain: A [11C]DASB PET study 2023 ·SHILAP Revista de lepidopterología ·Prabesh Kanel, Robert A. Koeppe, Vikas Kotagal, (unknown), Martijn L.T.M. Müller, Nicolaas I. Bohnen, Roger L. Albin	1
11	What is the Parkinson Pandemic? 2023 ·Movement Disorders ·Roger L. Albin, (unknown)	6
12	No Dopamine Agonist Modulation of Brain [¹⁸F]FEOBV Binding in Parkinson’s Disease 2022 ·Molecular Pharmaceutics ·Roger L. Albin, Prabesh Kanel, Teus van Laar, Sygrid van der Zee, (unknown), Robert A. Koeppe, Peter J. H. Scott, Nicolaas I. Bohnen	5
13	α4β2 ^* Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait–Balance Disorders 2021 ·Annals of Neurology ·Roger L. Albin, Martijn L.T.M. Müller, Nicolaas I. Bohnen, Cathie Spino, Martin Sarter, Robert A. Koeppe, (unknown), Kamin Kim, Cindy Lustig, William T. Dauer	15
14	Regional vesicular acetylcholine transporter distribution in human brain: A [¹⁸F]fluoroethoxybenzovesamicol positron emission tomography study 2018 ·The Journal of Comparative Neurology ·Roger L. Albin, Nicolaas I. Bohnen, Martijn L.T.M. Müller, William T. Dauer, Martin Sarter, Kirk A. Frey, Robert A. Koeppe	50
15	Normal Striatal Vesicular Acetylcholine Transporter Expression in Tourette Syndrome 2017 ·eNeuro ·Roger L. Albin, (unknown), Robert A. Koeppe	11
16	Differential Effects of Delayed Aging on Phenotype and Striatal Pathology in a Murine Model of Huntington Disease 2014 ·Journal of Neuroscience ·Sara J. Tallaksen‐Greene, Marianna Sadagurski, Li Zeng, (unknown), Matthew Perkins, Varuna C. Banduseela, Andrew P. Lieberman, Richard A. Miller, Henry L. Paulson, Roger L. Albin	12
17	Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal Study 2011 ·Journal of Nuclear Medicine ·Nicolaas I. Bohnen, Robert A. Koeppe, Satoshi Minoshima, Bruno Giordani, Roger L. Albin, Kirk A. Frey, David E. Kuhl	172
18	In VivoEvidence for NMDA Receptor-Mediated Excitotoxicity in a Murine Genetic Model of Huntington Disease 2009 ·Journal of Neuroscience ·Mary Y. Heng, Peter J. Detloff, (unknown), Joe Z. Tsien, Roger L. Albin	89
19	Metabotropic Glutamate Agonist-Induced Rotation: A Pharmacological, FOS Immunohistochemical, and [¹⁴C]-2-Deoxyglucose Autoradiographic Study 1997 ·Journal of Neuroscience ·Jennifer A. Kearney, Kirk A. Frey, Roger L. Albin	74
20	Diagnosis and treatment of pansinusitis: report of case. 1979 ·PubMed ·Roger L. Albin, John S. Wiener, (unknown), (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact